Melanotan I and Melanotan II: Chemical Identity Before Abbreviation
The numeral is part of the name
Melanotan I is associated with the Nle4,D-Phe7 analogue of alpha-melanocyte-stimulating hormone. Melanotan II identifies a different, cyclic fragment analogue. These are related molecules, but I and II should not be read as strengths, pack sizes or simple alternative abbreviations of the same peptide.
The original work on the Nle4,D-Phe7 alpha-MSH analogue describes a deliberately modified melanotropin. The early primary paper provides a sequence-specific starting point. Keep the substitutions in the record: norleucine and D-phenylalanine are chemical distinctions rather than incidental additions to a product name.
Linear sequence and cyclic topology differ
The Melanotan II pilot paper describes a cyclic heptapeptide with a lactam bridge. Its structural description distinguishes that molecule from the longer alpha-MSH analogue associated with Melanotan I. Ring closure changes molecular connectivity, so it belongs in an identity comparison alongside the residue sequence.
A list of amino acids alone may fail to show where a cyclic peptide is connected. Read the structural notation or diagram rather than flattening it into an ordinary linear sequence. Terminal groups and residue stereochemistry also matter when deciding whether two written descriptions represent the same molecule.
Receptor-family membership is not equivalence
Two melanocortin analogues can share a research family without having identical behaviour across receptors or experimental models. A common endpoint, such as a pigmentation-related assay signal, does not erase structural differences. Comparisons should specify the target system, endpoint and tested molecule rather than relying on the melanotan umbrella term.
Early experiments and a pilot human study also provide different kinds of evidence. The presence of a human study does not validate every later material sold under a similar name. Its preparation, study population and measured outcomes define what was investigated and what remains outside the evidence.
Keep MT2 searches chemically anchored
The Melanotan II catalogue entry uses the MT2 abbreviation. When linking a paper to that name, check that it concerns Melanotan II rather than MT-I, native alpha-MSH or another melanocortin analogue. A numeral lost in a search summary can lead to the wrong reference.
For an evidence record, preserve the full compound name, ring description and experimental model. The research section offers broader context for reading studies. Structural identity enables a meaningful comparison; it does not establish clinical suitability or justify transferring findings from one analogue to another.
Related research reading
- GHRH Analogues and Secretagogues: Separating Pathway Terms
- Thymosin Alpha-1 and Thymosin Beta-4 Are Distinct Materials
Explore the research blog and original batch-document library for further context.